Initial Dosing of ACE Inhibitors and ARBs
Start with the lowest recommended initial dose from the table below, then uptitrate to target doses over weeks to months as tolerated.
Starting Doses by Agent
ACE Inhibitors 1, 2, 3:
- Enalapril: Start 2.5 mg twice daily → Target 10-20 mg twice daily
- Lisinopril: Start 2.5-5 mg once daily → Target 20-40 mg once daily
- Ramipril: Start 1.25-2.5 mg once daily → Target 10 mg once daily
- Captopril: Start 6.25 mg three times daily → Target 50 mg three times daily
- Fosinopril: Start 5-10 mg once daily → Target 40 mg once daily
- Perindopril: Start 2 mg once daily → Target 8-16 mg once daily
- Quinapril: Start 5 mg twice daily → Target 20 mg twice daily
- Trandolapril: Start 1 mg once daily → Target 4 mg once daily
ARBs 1, 2, 3:
- Losartan: Start 25-50 mg once daily → Target 50-150 mg once daily
- Valsartan: Start 20-40 mg twice daily → Target 160 mg twice daily
- Candesartan: Start 4-8 mg once daily → Target 32 mg once daily
Critical Uptitration Strategy
The target doses listed above are what proved effective in clinical trials for reducing mortality and morbidity 1, 2. These medications were studied by starting low and systematically increasing to target doses regardless of symptom improvement at lower doses. Even if patients feel better on lower doses, continue uptitrating to achieve the proven target doses unless side effects prevent this 2, 3.
Monitoring Schedule
Reassess within 1-2 weeks after initiation or dose changes 1, 4:
- Blood pressure (including orthostatic measurements)
- Serum creatinine
- Serum potassium
When to Continue vs. Adjust
Continue uptitrating if 4:
- Creatinine rises <30% from baseline
- Potassium remains manageable with dietary modification or potassium binders
- Blood pressure tolerates increase (not causing symptomatic hypotension)
Stop or reduce dose if 4:
- Creatinine rises >30% within 4 weeks
- Uncontrolled hyperkalemia despite medical management
- Symptomatic hypotension
- Angioedema (permanently discontinue all ACE inhibitors; use extreme caution with ARBs) 1, 5
Context-Specific Considerations
For Heart Failure with Reduced Ejection Fraction
Start at the low end of dosing ranges and uptitrate systematically to target doses over 2-3 months 1, 2, 3. The mortality benefit comes from achieving target doses, not just starting therapy.
For Hypertension
Can start with slightly higher initial doses in uncomplicated hypertension 6, 7, 8. For example, lisinopril 10 mg daily or losartan 50 mg daily are reasonable starting points in otherwise healthy hypertensive patients.
For Chronic Kidney Disease with Albuminuria
Titrate to the highest approved dose tolerated 4. These patients particularly benefit from maximal renin-angiotensin system blockade, but require closer monitoring of creatinine and potassium.
Common Pitfalls to Avoid
First-dose hypotension risk is highest in 9:
- Volume-depleted patients
- Those on multiple antihypertensives
- Elderly patients
- Heart failure patients
- Renovascular hypertension
For high-risk patients, observe for at least 6 hours after the first dose 9.
Never combine ACE inhibitor + ARB - this increases adverse events without additional benefit 5, 10.
Absolute contraindications 1, 5:
- Pregnancy (discontinue immediately if pregnant or planning pregnancy) 4
- History of angioedema with ACE inhibitors (for ACE inhibitors)
- Bilateral renal artery stenosis
The evidence consistently shows that starting low and going slow with systematic uptitration to proven target doses maximizes benefit while minimizing harm 2, 3, 11.